DaVita
DVA
#2197
Rank
$8.39 B
Marketcap
$117.39
Share price
0.09%
Change (1 day)
-27.25%
Change (1 year)
DaVita Inc. is an American company providing dialysis services for patients with chronic and acute kidney failure.

EPS for DaVita (DVA)

EPS in 2025 (TTM): $9.94

According to DaVita's latest financial reports the company's current EPS (TTM) is $9.94. In 2024 the company made an earnings per share (EPS) of $11.03 an increase over its 2023 EPS that were of $7.61.

EPS history for DaVita from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)$9.94-9.88%
2024$11.0344.94%
2023$7.6127.26%
2022$5.98-35.56%
2021$9.2844.1%
2020$6.4419.7%
2019$5.38540.48%
2018$0.84-76.07%
2017$3.51-19.31%
2016$4.35242.52%
2015$1.27-62.87%
2014$3.4213.43%
2013$3.018.45%
2012$2.78

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Tenet Healthcare
THC
$14.70 47.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Pediatrix Medical Group
MD
$1.90-80.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Universal Health Services
UHS
$21.35 114.79%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
$10.25 3.12%๐Ÿ‡บ๐Ÿ‡ธ USA